Literature DB >> 10829098

Regulation of the kinin receptors after induction of myocardial infarction: a mini-review.

C Tschöpe1, S Heringer-Walther, T Walther.   

Abstract

It is well known that the responses to vasoactive kinin peptides are mediated through the activation of two receptors termed bradykinin receptor B1 (B1R) and B2 (B2R). The physiologically prominent B2R subtype has certainly been the subject of more intensive efforts in structure-function studies and physiological investigations. However, the B1R activated by a class of kinin metabolites has emerged as an important subject of investigation within the study of the kallikrein-kinin system (KKS). Its inducible character under stress and tissue injury is therefore a field of major interest. Although the KKS has been associated with cardiovascular regulation since its discovery at the beginning of the last century, less is known about the B1R and B2R regulation in cardiovascular diseases like hypertension, myocardial infarction (MI) and their complications. This mini-review will summarize our findings on B1R and B2R regulation after induction of MI using a rat model. We will develop the hypothesis that differences in the expression of these receptors may be associated with a dual pathway of the KKS in the complex mechanisms of myocardial remodeling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829098     DOI: 10.1590/s0100-879x2000000600011

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  Regul Pept       Date:  2006-12-28

2.  Expression of the genes encoding kinin receptors are increased in human carotid atherosclerotic plaques.

Authors:  Yapei Guo; Tiantian Liu; Xueyuan Li; Min Zhang; Lei Shi; Hengfang Liu
Journal:  Biomed Rep       Date:  2015-01-29

3.  Absence of ligand-induced regulation of kinin receptor expression in the rabbit.

Authors:  T Sabourin; K Guay; S Houle; J Bouthillier; D R Bachvarov; A Adam; F Marceau
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Ying Sun; Edward G Shesely; Nour-Eddine Rhaleb; Yun-He Liu; Tang-Dong Liao; James J Yang; Michael Bader; Xiao-Ping Yang
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

5.  Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.

Authors:  Bruna Visniauskas; Juliana C Perry; Guiomar N Gomes; Amanda Nogueira-Pedro; Edgar J Paredes-Gamero; Sergio Tufik; Jair R Chagas
Journal:  Physiol Rep       Date:  2021-05

6.  Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.

Authors:  Dongmei Wu; Xinchun Lin; Christian Bernloehr; Tobias Hildebrandt; Henri Doods
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats.

Authors:  Laszlo Deres; Krisztian Eros; Orsolya Horvath; Noemi Bencze; Csongor Cseko; Sandor Farkas; Tamas Habon; Kalman Toth; Robert Halmosi
Journal:  Front Physiol       Date:  2019-05-21       Impact factor: 4.566

8.  Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade.

Authors:  Dileep Reddy Rampa; Priya Murugesan; Honglu Chao; Huiying Feng; Wenxin Dai; Dongwon Lee; Anton Pekcec; Henri Doods; Dongmei Wu
Journal:  Respir Res       Date:  2021-10-30

9.  Early kidney damage induced by subchronic exposure to PM2.5 in rats.

Authors:  O G Aztatzi-Aguilar; M Uribe-Ramírez; J Narváez-Morales; A De Vizcaya-Ruiz; O Barbier
Journal:  Part Fibre Toxicol       Date:  2016-12-12       Impact factor: 9.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.